Cargando…
OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
Antisense long non-coding RNAs (AS lncRNAs) have increasingly been recognized as important regulators of gene expression and they have been found to play key roles in several diseases. However, very little is known about the role of AS lncRNAs in fibrotic diseases such as systemic sclerosis (SSc). O...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533854/ https://www.ncbi.nlm.nih.gov/pubmed/31156645 http://dx.doi.org/10.3389/fimmu.2019.01100 |
_version_ | 1783421292181979136 |
---|---|
author | Takata, Miki Pachera, Elena Frank-Bertoncelj, Mojca Kozlova, Anastasiia Jüngel, Astrid Whitfield, Michael L. Assassi, Shervin Calcagni, Maurizio de Vries-Bouwstra, Jeska Huizinga, Tom W. Kurreeman, Fina Kania, Gabriela Distler, Oliver |
author_facet | Takata, Miki Pachera, Elena Frank-Bertoncelj, Mojca Kozlova, Anastasiia Jüngel, Astrid Whitfield, Michael L. Assassi, Shervin Calcagni, Maurizio de Vries-Bouwstra, Jeska Huizinga, Tom W. Kurreeman, Fina Kania, Gabriela Distler, Oliver |
author_sort | Takata, Miki |
collection | PubMed |
description | Antisense long non-coding RNAs (AS lncRNAs) have increasingly been recognized as important regulators of gene expression and they have been found to play key roles in several diseases. However, very little is known about the role of AS lncRNAs in fibrotic diseases such as systemic sclerosis (SSc). Our recent screening experiments by RNA sequencing showed that ovarian tumor domain containing 6B antisense RNA1 (OTUD6B-AS1) and its sense gene OTUD6B were significantly downregulated in SSc skin biopsies. Therefore, we aimed to identify key regulators of OTUD6B-AS1 and to analyze the functional relevance of OTUD6B-AS1 in SSc. OTUD6B-AS1 and OTUD6B expression in SSc and healthy control (HC) dermal fibroblasts (Fb) after stimulation with transforming growth factor-β (TGFβ), Interleukin (IL)-4, IL-13, and platelet-derived growth factor (PDGF) was analyzed by qPCR. To identify the functional role of OTUD6B-AS1, dermal Fb or human pulmonary artery smooth muscle cells (HPASMC) were transfected with a locked nucleic acid antisense oligonucleotide (ASO) targeting OTUD6B-AS1. Proliferation was measured by BrdU and real-time proliferation assay. Apoptosis was measured by Caspase 3/7 assay and Western blot for cleaved caspase 3. While no difference was recorded at the basal level between HC and SSc dermal Fb, the expression of OTUD6B-AS1 and OTUD6B was significantly downregulated in both SSc and HC dermal Fb after PDGF stimulation in a time-dependent manner. Only mild and inconsistent effects were observed with TGFβ, IL-4, and IL-13. OTUD6B-AS1 knockdown in Fb and HPASMC did not affect extracellular matrix or pro-fibrotic/proinflammatory cytokine production. However, OTUD6B-AS1 knockdown significantly increased Cyclin D1 expression at the mRNA and protein level. Moreover, silencing of OTUD6B-AS1 significantly reduced proliferation and suppressed apoptosis in both dermal Fb and HPASMC. OTUD6B-AS1 knockdown did not affect OTUD6B expression at the mRNA level and protein level. Our data suggest that OTUD6B-AS1 regulates proliferation and apoptosis via cyclin D1 expression in a sense gene independent manner. This is the first report investigating the function of OTUD6B-AS1. Our data shed light on a novel apoptosis resistance mechanism in Fb and vascular smooth muscle cells that might be relevant for pathogenesis of SSc. |
format | Online Article Text |
id | pubmed-6533854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65338542019-05-31 OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis Takata, Miki Pachera, Elena Frank-Bertoncelj, Mojca Kozlova, Anastasiia Jüngel, Astrid Whitfield, Michael L. Assassi, Shervin Calcagni, Maurizio de Vries-Bouwstra, Jeska Huizinga, Tom W. Kurreeman, Fina Kania, Gabriela Distler, Oliver Front Immunol Immunology Antisense long non-coding RNAs (AS lncRNAs) have increasingly been recognized as important regulators of gene expression and they have been found to play key roles in several diseases. However, very little is known about the role of AS lncRNAs in fibrotic diseases such as systemic sclerosis (SSc). Our recent screening experiments by RNA sequencing showed that ovarian tumor domain containing 6B antisense RNA1 (OTUD6B-AS1) and its sense gene OTUD6B were significantly downregulated in SSc skin biopsies. Therefore, we aimed to identify key regulators of OTUD6B-AS1 and to analyze the functional relevance of OTUD6B-AS1 in SSc. OTUD6B-AS1 and OTUD6B expression in SSc and healthy control (HC) dermal fibroblasts (Fb) after stimulation with transforming growth factor-β (TGFβ), Interleukin (IL)-4, IL-13, and platelet-derived growth factor (PDGF) was analyzed by qPCR. To identify the functional role of OTUD6B-AS1, dermal Fb or human pulmonary artery smooth muscle cells (HPASMC) were transfected with a locked nucleic acid antisense oligonucleotide (ASO) targeting OTUD6B-AS1. Proliferation was measured by BrdU and real-time proliferation assay. Apoptosis was measured by Caspase 3/7 assay and Western blot for cleaved caspase 3. While no difference was recorded at the basal level between HC and SSc dermal Fb, the expression of OTUD6B-AS1 and OTUD6B was significantly downregulated in both SSc and HC dermal Fb after PDGF stimulation in a time-dependent manner. Only mild and inconsistent effects were observed with TGFβ, IL-4, and IL-13. OTUD6B-AS1 knockdown in Fb and HPASMC did not affect extracellular matrix or pro-fibrotic/proinflammatory cytokine production. However, OTUD6B-AS1 knockdown significantly increased Cyclin D1 expression at the mRNA and protein level. Moreover, silencing of OTUD6B-AS1 significantly reduced proliferation and suppressed apoptosis in both dermal Fb and HPASMC. OTUD6B-AS1 knockdown did not affect OTUD6B expression at the mRNA level and protein level. Our data suggest that OTUD6B-AS1 regulates proliferation and apoptosis via cyclin D1 expression in a sense gene independent manner. This is the first report investigating the function of OTUD6B-AS1. Our data shed light on a novel apoptosis resistance mechanism in Fb and vascular smooth muscle cells that might be relevant for pathogenesis of SSc. Frontiers Media S.A. 2019-05-17 /pmc/articles/PMC6533854/ /pubmed/31156645 http://dx.doi.org/10.3389/fimmu.2019.01100 Text en Copyright © 2019 Takata, Pachera, Frank-Bertoncelj, Kozlova, Jüngel, Whitfield, Assassi, Calcagni, Vries-Bouwstra, Huizinga, Kurreeman, Kania and Distler. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Takata, Miki Pachera, Elena Frank-Bertoncelj, Mojca Kozlova, Anastasiia Jüngel, Astrid Whitfield, Michael L. Assassi, Shervin Calcagni, Maurizio de Vries-Bouwstra, Jeska Huizinga, Tom W. Kurreeman, Fina Kania, Gabriela Distler, Oliver OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis |
title | OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis |
title_full | OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis |
title_fullStr | OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis |
title_full_unstemmed | OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis |
title_short | OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis |
title_sort | otud6b-as1 might be a novel regulator of apoptosis in systemic sclerosis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533854/ https://www.ncbi.nlm.nih.gov/pubmed/31156645 http://dx.doi.org/10.3389/fimmu.2019.01100 |
work_keys_str_mv | AT takatamiki otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT pacheraelena otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT frankbertonceljmojca otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT kozlovaanastasiia otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT jungelastrid otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT whitfieldmichaell otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT assassishervin otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT calcagnimaurizio otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT devriesbouwstrajeska otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT huizingatomw otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT kurreemanfina otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT kaniagabriela otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis AT distleroliver otud6bas1mightbeanovelregulatorofapoptosisinsystemicsclerosis |